Clinical Trial

Perception and Integration of Sensory Information in the Early Stages of Psychosis

Study acronym: PRIOR-ePSY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the early sensory system in clinical high risk (CHR), first episode psychosis (FEP) individuals and heathly controls. The main questions it aims to answer are: * Can anomalies in visual and auditory sensory processing serve as early markers of psychosis risk? * How are these sensory anomalies related to clinical symptom severity and emotional recognition deficits? Researchers will compare CHR and PEP participants to healthy controls to see if sensory processing differences can help identify individuals at higher risk of developing psychosis. Participants will: * Complete behavioral tasks evaluating visual processing (contrast sensitivity, contour integration, facial emotion recognition, visual inference using Necker cubes) and auditory processing (tone-matching, auditory emotion recognition). A temporal perception component will also be assessed within the auditory and emotion recognition tasks, rather than as a separate task. * Undergo electrophysiological assessments of retinal function using flash stimulation to record retinal potentials (a-wave, b-wave, phNR, oscillatory potentials). * Provide demographic, clinical, and neuropsychological data during study visits. * For CHR participants, attend follow-up visits up to 6 months post initial assessments to evaluate psychotic symptom progression.
Trial Details
NCT Number NCT07446569
Lead Sponsor Centre Psychothérapique de Nancy
Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions Early Psychosis, Schizophrenia Prodromal
Enrollment 294 participants
Start Date 2026-04
Primary Completion 2028-04 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-03